GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for biosynthetic peptidoglycan transglycosylase (Q5H1V9)

Analyse AlphaFold monomer V2.0 prediction for biosynthetic peptidoglycan… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q5H1V9
Type
protein
Length
245 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x04766A502967EAD08B1459294292a6c340B1D867
Molecule
Biosynthetic peptidoglycan transglycosylase
UniProt
Q5H1V9
Pockets
1 · best druggability 0.57

Structure

1 distinct chain · 59% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABiosynthetic peptidoglycan transglycosylaseprotein24559% helix, 3% strandQ5H1V9

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13760.570.7547empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.